1. 401Prognostic role of late gadolinium enhancement in patients with low-intermediate 5 year HCM SCD risk score: a multicenter study. (28th August 2018) Authors: Todiere, G; Barison, A; Grigoratos, C; Cosentino, F; Negri, F; Angeramo, F; Novo, G; Falletta, C; Gentile, G; Nugara, C; Emdin, M; Re, F; Zachara, E; Clemenza, F; Aquaro, G D Journal: European heart journal Issue: Volume 39(2018)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 673PDNab-paclitaxel (Nab) plus gemcitabine (G) is more effective than G alone in locally advanced, unresectable pancreatic cancer (LAUPC): The GAP trial, a GISCAD phase II comparative randomized trial. (1st October 2019) Authors: Cascinu, S; Berardi, R; Bianco, R; Bilancia, D; Zaniboni, A; Ferrari, D; Mosconi, S; Spallanzani, A; Cavanna, L; Leo, S; Negri, F; Beretta, G D; Sobrero, A; Banzi, M; Morabito, A; Bittoni, A; Marciano, R; Ferrara, D; Noventa, S; Piccirillo, M C Journal: Annals of oncology Issue: Volume 30(2019)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Epidemiology and clinics of mushroom poisoning in Northern Italy: A 21-year retrospective analysis. (July 2018) Authors: Cervellin, G; Comelli, I; Rastelli, G; Sanchis-Gomar, F; Negri, F; De Luca, C; Lippi, G Journal: Human & experimental toxicology Issue: Volume 37:Number 7(2018) Page Start: 697 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. O-007Liquid biopsy allows predicting benefit from rechallenge with cetuximab(cet)+irinotecan(iri) in RAS/BRAF wild-type mCRC patients(pts) with resistance to 1st-line cet+iri: Final results and translational analyses of the CRICKET study by GONO. (20th June 2018) Authors: Rossini, D; Cremolini, C; Conca, E; Del Re, M; Busico, A; Pietrantonio, F; Bergamo, F; Danesi, R; Cardellino, G; Tamburini, E; Dell'Aquila, E; Strippoli, A; Masi, G; Tonini, G; Negri, F; Corsi, D; Pella, N; Intini, R; Falcone, A; Santini, D Journal: Annals of oncology Issue: Volume 29(2018)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. PD-015Optimizing the use of first-line chemotherapy in metastatic colorectal cancer patients with mucinous histology. A multicenter, retrospective, combined analysis on 897 patients. (20th June 2018) Authors: Catalano, V; Bergamo, F; Cremolini, C; Vincenzi, B; Negri, F; Giordani, P; Santini, D; Sarti, D; Torresi, U; Bisonni, R; Silva, R; Rocchi, M; Lonardi, S; Falcone, A; Mattioli, R; Graziano, F Journal: Annals of oncology Issue: Volume 29(2018)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗